Skip to main
SNYR

SNYR Stock Forecast & Price Target

SNYR Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Synergy CHC is well-positioned to capitalize on the large and growing brain health supplements and energy RTD industries, with its strong and expanding FOCUSfactor product line and new focus plus energy RTD. Despite recent weaker results, the company has a solid financial performance and is making progress across its strategic priorities, with strong potential for near term catalysts to drive the stock price. The stock is currently undervalued due to concerns, but we believe the potential for growth and profitability presents high rewards for investors.

Bears say

Synergy CHC is facing weak financial performance with a decline in revenue and earnings in Q1 2026, despite strong performance in its beverages segment. The recent termination of a significant distribution deal and out-of-stock issues for key online items raise concerns about the company's ability to meet its goals. There are also significant potential risks such as balance sheet and liquidity concerns, changes in consumer demand, and competition that could impact the company's overall stock performance in the health and wellness industry.

SNYR has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Synergy CHC Corp (SNYR) Forecast

Analysts have given SNYR a Strong Buy based on their latest research and market trends.

According to 2 analysts, SNYR has a Strong Buy consensus rating as of Aug 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Synergy CHC Corp (SNYR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.